nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—ABCB1—ulcerative colitis	0.236	1	CbGaD
Dapagliflozin—CYP2A6—Nicotine—ulcerative colitis	0.0612	0.111	CbGbCtD
Dapagliflozin—CYP1A1—Nicotine—ulcerative colitis	0.0523	0.0949	CbGbCtD
Dapagliflozin—CYP1A1—Cholecalciferol—ulcerative colitis	0.0469	0.0851	CbGbCtD
Dapagliflozin—CYP2A6—Prednisolone—ulcerative colitis	0.0403	0.0731	CbGbCtD
Dapagliflozin—CYP3A4—Budesonide—ulcerative colitis	0.0281	0.051	CbGbCtD
Dapagliflozin—CYP2A6—Dexamethasone—ulcerative colitis	0.0237	0.0431	CbGbCtD
Dapagliflozin—CYP1A2—Nicotine—ulcerative colitis	0.0233	0.0424	CbGbCtD
Dapagliflozin—CYP2C9—Nicotine—ulcerative colitis	0.021	0.0382	CbGbCtD
Dapagliflozin—ABCB1—Methylprednisolone—ulcerative colitis	0.0209	0.038	CbGbCtD
Dapagliflozin—CYP1A1—Dexamethasone—ulcerative colitis	0.0203	0.0368	CbGbCtD
Dapagliflozin—CYP2D6—Nicotine—ulcerative colitis	0.0192	0.0349	CbGbCtD
Dapagliflozin—CYP2C9—Cholecalciferol—ulcerative colitis	0.0189	0.0342	CbGbCtD
Dapagliflozin—CYP2D6—Cholecalciferol—ulcerative colitis	0.0173	0.0313	CbGbCtD
Dapagliflozin—ABCB1—Betamethasone—ulcerative colitis	0.0136	0.0247	CbGbCtD
Dapagliflozin—ABCB1—Prednisolone—ulcerative colitis	0.0134	0.0244	CbGbCtD
Dapagliflozin—ABCB1—Hydrocortisone—ulcerative colitis	0.0127	0.0231	CbGbCtD
Dapagliflozin—ABCB1—Prednisone—ulcerative colitis	0.0127	0.023	CbGbCtD
Dapagliflozin—CYP3A4—Methylprednisolone—ulcerative colitis	0.0126	0.0228	CbGbCtD
Dapagliflozin—CYP3A4—Nicotine—ulcerative colitis	0.0122	0.0222	CbGbCtD
Dapagliflozin—CYP3A4—Cholecalciferol—ulcerative colitis	0.011	0.0199	CbGbCtD
Dapagliflozin—CYP3A4—Triamcinolone—ulcerative colitis	0.00951	0.0173	CbGbCtD
Dapagliflozin—CYP2C9—Dexamethasone—ulcerative colitis	0.00816	0.0148	CbGbCtD
Dapagliflozin—CYP3A4—Betamethasone—ulcerative colitis	0.00816	0.0148	CbGbCtD
Dapagliflozin—CYP3A4—Prednisolone—ulcerative colitis	0.00805	0.0146	CbGbCtD
Dapagliflozin—ABCB1—Dexamethasone—ulcerative colitis	0.00792	0.0144	CbGbCtD
Dapagliflozin—CYP3A4—Hydrocortisone—ulcerative colitis	0.00763	0.0139	CbGbCtD
Dapagliflozin—CYP3A4—Prednisone—ulcerative colitis	0.0076	0.0138	CbGbCtD
Dapagliflozin—CYP2D6—Dexamethasone—ulcerative colitis	0.00746	0.0136	CbGbCtD
Dapagliflozin—CYP3A4—Dexamethasone—ulcerative colitis	0.00475	0.00862	CbGbCtD
Dapagliflozin—SLC5A4—digestive system—ulcerative colitis	0.00273	0.191	CbGeAlD
Dapagliflozin—Canagliflozin—ALB—ulcerative colitis	0.00209	0.512	CrCbGaD
Dapagliflozin—SLC5A1—epithelium—ulcerative colitis	0.00206	0.144	CbGeAlD
Dapagliflozin—Canagliflozin—ABCB1—ulcerative colitis	0.00199	0.488	CrCbGaD
Dapagliflozin—SLC5A1—digestive system—ulcerative colitis	0.00157	0.11	CbGeAlD
Dapagliflozin—UGT2B4—liver—ulcerative colitis	0.00108	0.0754	CbGeAlD
Dapagliflozin—UGT1A9—digestive system—ulcerative colitis	0.000988	0.0692	CbGeAlD
Dapagliflozin—UGT2B7—digestive system—ulcerative colitis	0.000796	0.0557	CbGeAlD
Dapagliflozin—UGT1A9—liver—ulcerative colitis	0.000736	0.0515	CbGeAlD
Dapagliflozin—UGT2B7—liver—ulcerative colitis	0.000593	0.0415	CbGeAlD
Dapagliflozin—Extravasation—Betamethasone—ulcerative colitis	0.000505	0.00494	CcSEcCtD
Dapagliflozin—Extravasation—Dexamethasone—ulcerative colitis	0.000505	0.00494	CcSEcCtD
Dapagliflozin—Infestation NOS—Budesonide—ulcerative colitis	0.000499	0.00488	CcSEcCtD
Dapagliflozin—Infestation—Budesonide—ulcerative colitis	0.000499	0.00488	CcSEcCtD
Dapagliflozin—Fungal infection—Prednisone—ulcerative colitis	0.000497	0.00486	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000494	0.00483	CcSEcCtD
Dapagliflozin—Blood creatinine increased—Mesalazine—ulcerative colitis	0.000493	0.00482	CcSEcCtD
Dapagliflozin—Hypertension—Nicotine—ulcerative colitis	0.000489	0.00478	CcSEcCtD
Dapagliflozin—Urinary tract infection—Budesonide—ulcerative colitis	0.000485	0.00474	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Mesalazine—ulcerative colitis	0.000481	0.0047	CcSEcCtD
Dapagliflozin—Oedema—Mercaptopurine—ulcerative colitis	0.000477	0.00466	CcSEcCtD
Dapagliflozin—Discomfort—Nicotine—ulcerative colitis	0.000476	0.00466	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Mesalazine—ulcerative colitis	0.000471	0.00461	CcSEcCtD
Dapagliflozin—Skin disorder—Mercaptopurine—ulcerative colitis	0.000463	0.00453	CcSEcCtD
Dapagliflozin—Oedema—Nicotine—ulcerative colitis	0.000462	0.00452	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Nicotine—ulcerative colitis	0.000462	0.00452	CcSEcCtD
Dapagliflozin—Influenza—Mesalazine—ulcerative colitis	0.000455	0.00445	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Nicotine—ulcerative colitis	0.000447	0.00437	CcSEcCtD
Dapagliflozin—Infestation—Azathioprine—ulcerative colitis	0.000445	0.00436	CcSEcCtD
Dapagliflozin—Infestation NOS—Azathioprine—ulcerative colitis	0.000445	0.00436	CcSEcCtD
Dapagliflozin—Angina pectoris—Mesalazine—ulcerative colitis	0.000443	0.00434	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Budesonide—ulcerative colitis	0.000442	0.00433	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Prednisolone—ulcerative colitis	0.000441	0.00431	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Budesonide—ulcerative colitis	0.00044	0.0043	CcSEcCtD
Dapagliflozin—Urethral disorder—Budesonide—ulcerative colitis	0.000439	0.00429	CcSEcCtD
Dapagliflozin—Hypotension—Nicotine—ulcerative colitis	0.000432	0.00422	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Hydrocortisone—ulcerative colitis	0.00043	0.00421	CcSEcCtD
Dapagliflozin—Dysuria—Mesalazine—ulcerative colitis	0.000425	0.00416	CcSEcCtD
Dapagliflozin—CYP2A6—liver—ulcerative colitis	0.000425	0.0298	CbGeAlD
Dapagliflozin—Pollakiuria—Mesalazine—ulcerative colitis	0.00042	0.00411	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000412	0.00403	CcSEcCtD
Dapagliflozin—Infestation—Mesalazine—ulcerative colitis	0.000406	0.00397	CcSEcCtD
Dapagliflozin—Infestation NOS—Mesalazine—ulcerative colitis	0.000406	0.00397	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Triamcinolone—ulcerative colitis	0.000405	0.00396	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Methylprednisolone—ulcerative colitis	0.000404	0.00396	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000399	0.0039	CcSEcCtD
Dapagliflozin—Renal failure—Mesalazine—ulcerative colitis	0.000399	0.0039	CcSEcCtD
Dapagliflozin—Constipation—Nicotine—ulcerative colitis	0.000395	0.00386	CcSEcCtD
Dapagliflozin—Urinary tract infection—Mesalazine—ulcerative colitis	0.000394	0.00386	CcSEcCtD
Dapagliflozin—Malnutrition—Budesonide—ulcerative colitis	0.00039	0.00381	CcSEcCtD
Dapagliflozin—CYP1A1—epithelium—ulcerative colitis	0.000389	0.0272	CbGeAlD
Dapagliflozin—Back pain—Budesonide—ulcerative colitis	0.000377	0.00369	CcSEcCtD
Dapagliflozin—Body temperature increased—Mercaptopurine—ulcerative colitis	0.000377	0.00369	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Dexamethasone—ulcerative colitis	0.000368	0.0036	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Betamethasone—ulcerative colitis	0.000368	0.0036	CcSEcCtD
Dapagliflozin—Urticaria—Nicotine—ulcerative colitis	0.000367	0.00359	CcSEcCtD
Dapagliflozin—Body temperature increased—Nicotine—ulcerative colitis	0.000365	0.00357	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Mesalazine—ulcerative colitis	0.00036	0.00352	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Mesalazine—ulcerative colitis	0.000358	0.0035	CcSEcCtD
Dapagliflozin—Urethral disorder—Mesalazine—ulcerative colitis	0.000357	0.00349	CcSEcCtD
Dapagliflozin—Angioedema—Budesonide—ulcerative colitis	0.000356	0.00348	CcSEcCtD
Dapagliflozin—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000351	0.00344	CcSEcCtD
Dapagliflozin—Hypersensitivity—Nicotine—ulcerative colitis	0.00034	0.00333	CcSEcCtD
Dapagliflozin—Hypertension—Budesonide—ulcerative colitis	0.000337	0.00329	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.00033	0.00322	CcSEcCtD
Dapagliflozin—Discomfort—Budesonide—ulcerative colitis	0.000328	0.00321	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Prednisone—ulcerative colitis	0.00032	0.00313	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Budesonide—ulcerative colitis	0.000318	0.00311	CcSEcCtD
Dapagliflozin—Infection—Budesonide—ulcerative colitis	0.000316	0.00309	CcSEcCtD
Dapagliflozin—Skin disorder—Budesonide—ulcerative colitis	0.000309	0.00302	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Budesonide—ulcerative colitis	0.000308	0.00301	CcSEcCtD
Dapagliflozin—Back pain—Mesalazine—ulcerative colitis	0.000307	0.003	CcSEcCtD
Dapagliflozin—Dizziness—Nicotine—ulcerative colitis	0.000305	0.00299	CcSEcCtD
Dapagliflozin—Influenza—Triamcinolone—ulcerative colitis	0.000305	0.00298	CcSEcCtD
Dapagliflozin—Rash—Mercaptopurine—ulcerative colitis	0.000301	0.00294	CcSEcCtD
Dapagliflozin—Dermatitis—Mercaptopurine—ulcerative colitis	0.0003	0.00294	CcSEcCtD
Dapagliflozin—CYP1A2—digestive system—ulcerative colitis	0.0003	0.021	CbGeAlD
Dapagliflozin—CYP1A1—digestive system—ulcerative colitis	0.000296	0.0207	CbGeAlD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000294	0.00288	CcSEcCtD
Dapagliflozin—Discomfort—Azathioprine—ulcerative colitis	0.000293	0.00286	CcSEcCtD
Dapagliflozin—Rash—Nicotine—ulcerative colitis	0.000291	0.00285	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Prednisolone—ulcerative colitis	0.000291	0.00285	CcSEcCtD
Dapagliflozin—Dermatitis—Nicotine—ulcerative colitis	0.000291	0.00285	CcSEcCtD
Dapagliflozin—Angioedema—Mesalazine—ulcerative colitis	0.00029	0.00283	CcSEcCtD
Dapagliflozin—Myocardial infarction—Prednisolone—ulcerative colitis	0.00029	0.00283	CcSEcCtD
Dapagliflozin—Headache—Nicotine—ulcerative colitis	0.000289	0.00283	CcSEcCtD
Dapagliflozin—Infestation—Hydrocortisone—ulcerative colitis	0.000288	0.00282	CcSEcCtD
Dapagliflozin—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000288	0.00282	CcSEcCtD
Dapagliflozin—CYP2C9—digestive system—ulcerative colitis	0.000284	0.0199	CbGeAlD
Dapagliflozin—Acute coronary syndrome—Hydrocortisone—ulcerative colitis	0.000284	0.00278	CcSEcCtD
Dapagliflozin—Nausea—Mercaptopurine—ulcerative colitis	0.000283	0.00277	CcSEcCtD
Dapagliflozin—Myocardial infarction—Hydrocortisone—ulcerative colitis	0.000283	0.00277	CcSEcCtD
Dapagliflozin—Infection—Azathioprine—ulcerative colitis	0.000282	0.00276	CcSEcCtD
Dapagliflozin—Skin disorder—Azathioprine—ulcerative colitis	0.000276	0.0027	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000275	0.00269	CcSEcCtD
Dapagliflozin—Nausea—Nicotine—ulcerative colitis	0.000274	0.00268	CcSEcCtD
Dapagliflozin—Hypertension—Mesalazine—ulcerative colitis	0.000274	0.00268	CcSEcCtD
Dapagliflozin—Constipation—Budesonide—ulcerative colitis	0.000272	0.00266	CcSEcCtD
Dapagliflozin—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000271	0.00265	CcSEcCtD
Dapagliflozin—Infestation—Methylprednisolone—ulcerative colitis	0.000271	0.00265	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000268	0.00262	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Triamcinolone—ulcerative colitis	0.000268	0.00262	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Methylprednisolone—ulcerative colitis	0.000267	0.00261	CcSEcCtD
Dapagliflozin—Discomfort—Mesalazine—ulcerative colitis	0.000267	0.00261	CcSEcCtD
Dapagliflozin—Myocardial infarction—Triamcinolone—ulcerative colitis	0.000266	0.0026	CcSEcCtD
Dapagliflozin—Myocardial infarction—Methylprednisolone—ulcerative colitis	0.000266	0.0026	CcSEcCtD
Dapagliflozin—Hypotension—Azathioprine—ulcerative colitis	0.000265	0.0026	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Mesalazine—ulcerative colitis	0.000259	0.00253	CcSEcCtD
Dapagliflozin—Oedema—Mesalazine—ulcerative colitis	0.000259	0.00253	CcSEcCtD
Dapagliflozin—Infection—Mesalazine—ulcerative colitis	0.000257	0.00251	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000254	0.00249	CcSEcCtD
Dapagliflozin—Urticaria—Budesonide—ulcerative colitis	0.000253	0.00247	CcSEcCtD
Dapagliflozin—Body temperature increased—Budesonide—ulcerative colitis	0.000252	0.00246	CcSEcCtD
Dapagliflozin—Skin disorder—Mesalazine—ulcerative colitis	0.000251	0.00246	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Mesalazine—ulcerative colitis	0.00025	0.00245	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000245	0.0024	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.000243	0.00238	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.000243	0.00238	CcSEcCtD
Dapagliflozin—Hypotension—Mesalazine—ulcerative colitis	0.000242	0.00237	CcSEcCtD
Dapagliflozin—Myocardial infarction—Dexamethasone—ulcerative colitis	0.000242	0.00236	CcSEcCtD
Dapagliflozin—Myocardial infarction—Betamethasone—ulcerative colitis	0.000242	0.00236	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000239	0.00234	CcSEcCtD
Dapagliflozin—Hypersensitivity—Budesonide—ulcerative colitis	0.000234	0.00229	CcSEcCtD
Dapagliflozin—Malnutrition—Hydrocortisone—ulcerative colitis	0.000225	0.00221	CcSEcCtD
Dapagliflozin—Body temperature increased—Azathioprine—ulcerative colitis	0.000225	0.0022	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000223	0.00219	CcSEcCtD
Dapagliflozin—CYP1A2—liver—ulcerative colitis	0.000223	0.0156	CbGeAlD
Dapagliflozin—Constipation—Mesalazine—ulcerative colitis	0.000221	0.00216	CcSEcCtD
Dapagliflozin—CYP1A1—liver—ulcerative colitis	0.00022	0.0154	CbGeAlD
Dapagliflozin—CYP3A4—digestive system—ulcerative colitis	0.000217	0.0152	CbGeAlD
Dapagliflozin—CYP2D6—digestive system—ulcerative colitis	0.000213	0.0149	CbGeAlD
Dapagliflozin—CYP2C9—liver—ulcerative colitis	0.000212	0.0148	CbGeAlD
Dapagliflozin—Malnutrition—Methylprednisolone—ulcerative colitis	0.000212	0.00207	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000212	0.00207	CcSEcCtD
Dapagliflozin—Angioedema—Prednisolone—ulcerative colitis	0.000211	0.00206	CcSEcCtD
Dapagliflozin—Myocardial infarction—Prednisone—ulcerative colitis	0.00021	0.00206	CcSEcCtD
Dapagliflozin—Dizziness—Budesonide—ulcerative colitis	0.00021	0.00206	CcSEcCtD
Dapagliflozin—Hypersensitivity—Azathioprine—ulcerative colitis	0.000209	0.00205	CcSEcCtD
Dapagliflozin—Angioedema—Hydrocortisone—ulcerative colitis	0.000206	0.00202	CcSEcCtD
Dapagliflozin—Urticaria—Mesalazine—ulcerative colitis	0.000206	0.00201	CcSEcCtD
Dapagliflozin—Back pain—Triamcinolone—ulcerative colitis	0.000205	0.00201	CcSEcCtD
Dapagliflozin—Body temperature increased—Mesalazine—ulcerative colitis	0.000205	0.002	CcSEcCtD
Dapagliflozin—ABCB1—epithelium—ulcerative colitis	0.000202	0.0141	CbGeAlD
Dapagliflozin—Rash—Budesonide—ulcerative colitis	0.000201	0.00196	CcSEcCtD
Dapagliflozin—Dermatitis—Budesonide—ulcerative colitis	0.0002	0.00196	CcSEcCtD
Dapagliflozin—Headache—Budesonide—ulcerative colitis	0.000199	0.00195	CcSEcCtD
Dapagliflozin—Hypertension—Prednisolone—ulcerative colitis	0.000199	0.00195	CcSEcCtD
Dapagliflozin—Hypertension—Hydrocortisone—ulcerative colitis	0.000195	0.0019	CcSEcCtD
Dapagliflozin—Discomfort—Prednisolone—ulcerative colitis	0.000194	0.0019	CcSEcCtD
Dapagliflozin—Angioedema—Triamcinolone—ulcerative colitis	0.000194	0.0019	CcSEcCtD
Dapagliflozin—Angioedema—Methylprednisolone—ulcerative colitis	0.000194	0.00189	CcSEcCtD
Dapagliflozin—Hypersensitivity—Mesalazine—ulcerative colitis	0.000191	0.00186	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000191	0.00186	CcSEcCtD
Dapagliflozin—Discomfort—Hydrocortisone—ulcerative colitis	0.00019	0.00186	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Prednisone—ulcerative colitis	0.000189	0.00185	CcSEcCtD
Dapagliflozin—Nausea—Budesonide—ulcerative colitis	0.000189	0.00185	CcSEcCtD
Dapagliflozin—Oedema—Prednisolone—ulcerative colitis	0.000188	0.00184	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000188	0.00184	CcSEcCtD
Dapagliflozin—Dizziness—Azathioprine—ulcerative colitis	0.000188	0.00184	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000184	0.0018	CcSEcCtD
Dapagliflozin—Oedema—Hydrocortisone—ulcerative colitis	0.000184	0.0018	CcSEcCtD
Dapagliflozin—Hypertension—Triamcinolone—ulcerative colitis	0.000183	0.00179	CcSEcCtD
Dapagliflozin—Hypertension—Methylprednisolone—ulcerative colitis	0.000183	0.00179	CcSEcCtD
Dapagliflozin—Infection—Hydrocortisone—ulcerative colitis	0.000183	0.00179	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000182	0.00178	CcSEcCtD
Dapagliflozin—Rash—Azathioprine—ulcerative colitis	0.000179	0.00175	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000179	0.00175	CcSEcCtD
Dapagliflozin—Dermatitis—Azathioprine—ulcerative colitis	0.000179	0.00175	CcSEcCtD
Dapagliflozin—Skin disorder—Hydrocortisone—ulcerative colitis	0.000179	0.00175	CcSEcCtD
Dapagliflozin—Discomfort—Triamcinolone—ulcerative colitis	0.000179	0.00175	CcSEcCtD
Dapagliflozin—Discomfort—Methylprednisolone—ulcerative colitis	0.000178	0.00174	CcSEcCtD
Dapagliflozin—Headache—Azathioprine—ulcerative colitis	0.000178	0.00174	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000178	0.00174	CcSEcCtD
Dapagliflozin—Angioedema—Dexamethasone—ulcerative colitis	0.000176	0.00172	CcSEcCtD
Dapagliflozin—Angioedema—Betamethasone—ulcerative colitis	0.000176	0.00172	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000173	0.00169	CcSEcCtD
Dapagliflozin—Oedema—Triamcinolone—ulcerative colitis	0.000173	0.00169	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000173	0.00169	CcSEcCtD
Dapagliflozin—Infection—Triamcinolone—ulcerative colitis	0.000172	0.00168	CcSEcCtD
Dapagliflozin—Hypotension—Hydrocortisone—ulcerative colitis	0.000172	0.00168	CcSEcCtD
Dapagliflozin—Infection—Methylprednisolone—ulcerative colitis	0.000172	0.00168	CcSEcCtD
Dapagliflozin—Dizziness—Mesalazine—ulcerative colitis	0.000171	0.00167	CcSEcCtD
Dapagliflozin—Nausea—Azathioprine—ulcerative colitis	0.000169	0.00165	CcSEcCtD
Dapagliflozin—Skin disorder—Methylprednisolone—ulcerative colitis	0.000168	0.00164	CcSEcCtD
Dapagliflozin—Malnutrition—Prednisone—ulcerative colitis	0.000168	0.00164	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000167	0.00164	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000167	0.00163	CcSEcCtD
Dapagliflozin—Hypertension—Dexamethasone—ulcerative colitis	0.000166	0.00163	CcSEcCtD
Dapagliflozin—Hypertension—Betamethasone—ulcerative colitis	0.000166	0.00163	CcSEcCtD
Dapagliflozin—Rash—Mesalazine—ulcerative colitis	0.000163	0.0016	CcSEcCtD
Dapagliflozin—Dermatitis—Mesalazine—ulcerative colitis	0.000163	0.00159	CcSEcCtD
Dapagliflozin—Headache—Mesalazine—ulcerative colitis	0.000162	0.00159	CcSEcCtD
Dapagliflozin—Discomfort—Dexamethasone—ulcerative colitis	0.000162	0.00158	CcSEcCtD
Dapagliflozin—Discomfort—Betamethasone—ulcerative colitis	0.000162	0.00158	CcSEcCtD
Dapagliflozin—CYP3A4—liver—ulcerative colitis	0.000162	0.0113	CbGeAlD
Dapagliflozin—Hypotension—Methylprednisolone—ulcerative colitis	0.000162	0.00158	CcSEcCtD
Dapagliflozin—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000159	0.00172	CbGpPWpGaD
Dapagliflozin—CYP2D6—liver—ulcerative colitis	0.000159	0.0111	CbGeAlD
Dapagliflozin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000159	0.00155	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000157	0.00154	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000157	0.00154	CcSEcCtD
Dapagliflozin—Oedema—Dexamethasone—ulcerative colitis	0.000157	0.00154	CcSEcCtD
Dapagliflozin—Oedema—Betamethasone—ulcerative colitis	0.000157	0.00154	CcSEcCtD
Dapagliflozin—Infection—Dexamethasone—ulcerative colitis	0.000156	0.00153	CcSEcCtD
Dapagliflozin—Infection—Betamethasone—ulcerative colitis	0.000156	0.00153	CcSEcCtD
Dapagliflozin—ABCB1—lymphoid tissue—ulcerative colitis	0.000155	0.0109	CbGeAlD
Dapagliflozin—Nausea—Mesalazine—ulcerative colitis	0.000154	0.0015	CcSEcCtD
Dapagliflozin—ABCB1—digestive system—ulcerative colitis	0.000154	0.0108	CbGeAlD
Dapagliflozin—Angioedema—Prednisone—ulcerative colitis	0.000153	0.0015	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000152	0.00149	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000152	0.00149	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—MAML2—ulcerative colitis	0.000152	0.00164	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000151	0.00163	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.00015	0.00162	CbGpPWpGaD
Dapagliflozin—Urticaria—Prednisolone—ulcerative colitis	0.00015	0.00146	CcSEcCtD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000149	0.00161	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—PTGS1—ulcerative colitis	0.000147	0.00159	CbGpPWpGaD
Dapagliflozin—Hypotension—Betamethasone—ulcerative colitis	0.000147	0.00144	CcSEcCtD
Dapagliflozin—Hypotension—Dexamethasone—ulcerative colitis	0.000147	0.00144	CcSEcCtD
Dapagliflozin—Urticaria—Hydrocortisone—ulcerative colitis	0.000146	0.00143	CcSEcCtD
Dapagliflozin—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000145	0.00142	CcSEcCtD
Dapagliflozin—Hypertension—Prednisone—ulcerative colitis	0.000145	0.00142	CcSEcCtD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000145	0.00157	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000144	0.00156	CbGpPWpGaD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000142	0.00139	CcSEcCtD
Dapagliflozin—Discomfort—Prednisone—ulcerative colitis	0.000141	0.00138	CcSEcCtD
Dapagliflozin—UGT2B4—Metabolism—DLD—ulcerative colitis	0.000141	0.00152	CbGpPWpGaD
Dapagliflozin—Hypersensitivity—Prednisolone—ulcerative colitis	0.000139	0.00136	CcSEcCtD
Dapagliflozin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000138	0.00149	CbGpPWpGaD
Dapagliflozin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000138	0.00149	CbGpPWpGaD
Dapagliflozin—Urticaria—Triamcinolone—ulcerative colitis	0.000138	0.00135	CcSEcCtD
Dapagliflozin—Urticaria—Methylprednisolone—ulcerative colitis	0.000137	0.00134	CcSEcCtD
Dapagliflozin—Body temperature increased—Triamcinolone—ulcerative colitis	0.000137	0.00134	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Prednisone—ulcerative colitis	0.000137	0.00134	CcSEcCtD
Dapagliflozin—Oedema—Prednisone—ulcerative colitis	0.000137	0.00134	CcSEcCtD
Dapagliflozin—Infection—Prednisone—ulcerative colitis	0.000136	0.00133	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000136	0.00133	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000136	0.00133	CcSEcCtD
Dapagliflozin—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000136	0.00133	CcSEcCtD
Dapagliflozin—Skin disorder—Prednisone—ulcerative colitis	0.000133	0.0013	CcSEcCtD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000133	0.00143	CbGpPWpGaD
Dapagliflozin—Hyperhidrosis—Prednisone—ulcerative colitis	0.000132	0.00129	CcSEcCtD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000132	0.00142	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000132	0.00142	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—SLC11A1—ulcerative colitis	0.000128	0.00138	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—SLC11A1—ulcerative colitis	0.000128	0.00138	CbGpPWpGaD
Dapagliflozin—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000128	0.00125	CcSEcCtD
Dapagliflozin—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000127	0.00125	CcSEcCtD
Dapagliflozin—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000127	0.00138	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000126	0.00136	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CALM3—ulcerative colitis	0.000125	0.00135	CbGpPWpGaD
Dapagliflozin—Urticaria—Dexamethasone—ulcerative colitis	0.000125	0.00122	CcSEcCtD
Dapagliflozin—Urticaria—Betamethasone—ulcerative colitis	0.000125	0.00122	CcSEcCtD
Dapagliflozin—Dizziness—Prednisolone—ulcerative colitis	0.000125	0.00122	CcSEcCtD
Dapagliflozin—Body temperature increased—Dexamethasone—ulcerative colitis	0.000124	0.00122	CcSEcCtD
Dapagliflozin—Body temperature increased—Betamethasone—ulcerative colitis	0.000124	0.00122	CcSEcCtD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000123	0.00133	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000123	0.00133	CbGpPWpGaD
Dapagliflozin—Dizziness—Hydrocortisone—ulcerative colitis	0.000122	0.00119	CcSEcCtD
Dapagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.00012	0.0013	CbGpPWpGaD
Dapagliflozin—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.00012	0.0013	CbGpPWpGaD
Dapagliflozin—Rash—Prednisolone—ulcerative colitis	0.000119	0.00116	CcSEcCtD
Dapagliflozin—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000119	0.00128	CbGpPWpGaD
Dapagliflozin—Dermatitis—Prednisolone—ulcerative colitis	0.000119	0.00116	CcSEcCtD
Dapagliflozin—Headache—Prednisolone—ulcerative colitis	0.000118	0.00115	CcSEcCtD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000117	0.00127	CbGpPWpGaD
Dapagliflozin—Constipation—Prednisone—ulcerative colitis	0.000117	0.00115	CcSEcCtD
Dapagliflozin—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000117	0.00127	CbGpPWpGaD
Dapagliflozin—CYP1A1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000117	0.00126	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTGS1—ulcerative colitis	0.000116	0.00126	CbGpPWpGaD
Dapagliflozin—Rash—Hydrocortisone—ulcerative colitis	0.000116	0.00113	CcSEcCtD
Dapagliflozin—Dermatitis—Hydrocortisone—ulcerative colitis	0.000116	0.00113	CcSEcCtD
Dapagliflozin—Headache—Hydrocortisone—ulcerative colitis	0.000115	0.00113	CcSEcCtD
Dapagliflozin—SLC5A2—Disease—MAML2—ulcerative colitis	0.000115	0.00124	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—MAML2—ulcerative colitis	0.000115	0.00124	CbGpPWpGaD
Dapagliflozin—Dizziness—Triamcinolone—ulcerative colitis	0.000115	0.00112	CcSEcCtD
Dapagliflozin—ABCB1—liver—ulcerative colitis	0.000114	0.00801	CbGeAlD
Dapagliflozin—Dizziness—Methylprednisolone—ulcerative colitis	0.000114	0.00112	CcSEcCtD
Dapagliflozin—CYP1A1—Oxidative Stress—NFKB1—ulcerative colitis	0.000114	0.00123	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—PTGS1—ulcerative colitis	0.000113	0.00123	CbGpPWpGaD
Dapagliflozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000112	0.00122	CbGpPWpGaD
Dapagliflozin—Nausea—Prednisolone—ulcerative colitis	0.000112	0.00109	CcSEcCtD
Dapagliflozin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000112	0.00121	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	0.00011	0.00119	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000109	0.00118	CbGpPWpGaD
Dapagliflozin—Nausea—Hydrocortisone—ulcerative colitis	0.000109	0.00107	CcSEcCtD
Dapagliflozin—Rash—Triamcinolone—ulcerative colitis	0.000109	0.00107	CcSEcCtD
Dapagliflozin—Dermatitis—Triamcinolone—ulcerative colitis	0.000109	0.00107	CcSEcCtD
Dapagliflozin—Rash—Methylprednisolone—ulcerative colitis	0.000109	0.00107	CcSEcCtD
Dapagliflozin—Dermatitis—Methylprednisolone—ulcerative colitis	0.000109	0.00107	CcSEcCtD
Dapagliflozin—Urticaria—Prednisone—ulcerative colitis	0.000109	0.00106	CcSEcCtD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000109	0.00118	CbGpPWpGaD
Dapagliflozin—Headache—Triamcinolone—ulcerative colitis	0.000109	0.00106	CcSEcCtD
Dapagliflozin—Headache—Methylprednisolone—ulcerative colitis	0.000108	0.00106	CcSEcCtD
Dapagliflozin—Body temperature increased—Prednisone—ulcerative colitis	0.000108	0.00106	CcSEcCtD
Dapagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000107	0.00115	CbGpPWpGaD
Dapagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000106	0.00115	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CALM3—ulcerative colitis	0.000105	0.00113	CbGpPWpGaD
Dapagliflozin—Dizziness—Dexamethasone—ulcerative colitis	0.000104	0.00102	CcSEcCtD
Dapagliflozin—Dizziness—Betamethasone—ulcerative colitis	0.000104	0.00102	CcSEcCtD
Dapagliflozin—Nausea—Triamcinolone—ulcerative colitis	0.000103	0.00101	CcSEcCtD
Dapagliflozin—Nausea—Methylprednisolone—ulcerative colitis	0.000103	0.001	CcSEcCtD
Dapagliflozin—UGT1A9—PPARA activates gene expression—PPARG—ulcerative colitis	0.000103	0.00111	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000101	0.0011	CbGpPWpGaD
Dapagliflozin—Hypersensitivity—Prednisone—ulcerative colitis	0.000101	0.000987	CcSEcCtD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	0.0001	0.00109	CbGpPWpGaD
Dapagliflozin—Rash—Dexamethasone—ulcerative colitis	9.91e-05	0.00097	CcSEcCtD
Dapagliflozin—Rash—Betamethasone—ulcerative colitis	9.91e-05	0.00097	CcSEcCtD
Dapagliflozin—Dermatitis—Betamethasone—ulcerative colitis	9.9e-05	0.000969	CcSEcCtD
Dapagliflozin—Dermatitis—Dexamethasone—ulcerative colitis	9.9e-05	0.000969	CcSEcCtD
Dapagliflozin—Headache—Dexamethasone—ulcerative colitis	9.85e-05	0.000963	CcSEcCtD
Dapagliflozin—Headache—Betamethasone—ulcerative colitis	9.85e-05	0.000963	CcSEcCtD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	9.7e-05	0.00105	CbGpPWpGaD
Dapagliflozin—CYP2A6—Fluoropyrimidine Activity—TP53—ulcerative colitis	9.69e-05	0.00105	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	9.68e-05	0.00105	CbGpPWpGaD
Dapagliflozin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	9.6e-05	0.00104	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	9.57e-05	0.00104	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CALM3—ulcerative colitis	9.47e-05	0.00102	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CALM3—ulcerative colitis	9.47e-05	0.00102	CbGpPWpGaD
Dapagliflozin—Nausea—Betamethasone—ulcerative colitis	9.34e-05	0.000913	CcSEcCtD
Dapagliflozin—Nausea—Dexamethasone—ulcerative colitis	9.34e-05	0.000913	CcSEcCtD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	9.3e-05	0.00101	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—ADCY5—ulcerative colitis	9.06e-05	0.000981	CbGpPWpGaD
Dapagliflozin—Dizziness—Prednisone—ulcerative colitis	9.05e-05	0.000886	CcSEcCtD
Dapagliflozin—SLC5A2—Metabolism—PTGS1—ulcerative colitis	8.81e-05	0.000953	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTGS1—ulcerative colitis	8.81e-05	0.000953	CbGpPWpGaD
Dapagliflozin—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	8.79e-05	0.000951	CbGpPWpGaD
Dapagliflozin—CYP1A1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	8.7e-05	0.000942	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	8.66e-05	0.000937	CbGpPWpGaD
Dapagliflozin—Rash—Prednisone—ulcerative colitis	8.63e-05	0.000844	CcSEcCtD
Dapagliflozin—Dermatitis—Prednisone—ulcerative colitis	8.62e-05	0.000844	CcSEcCtD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	8.62e-05	0.000933	CbGpPWpGaD
Dapagliflozin—Headache—Prednisone—ulcerative colitis	8.58e-05	0.000839	CcSEcCtD
Dapagliflozin—ABCB1—Allograft Rejection—IL10—ulcerative colitis	8.55e-05	0.000925	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—PTGS1—ulcerative colitis	8.45e-05	0.000915	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.24e-05	0.000891	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.24e-05	0.000891	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	8.17e-05	0.000884	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ABCB1—ulcerative colitis	8.14e-05	0.00088	CbGpPWpGaD
Dapagliflozin—Nausea—Prednisone—ulcerative colitis	8.13e-05	0.000795	CcSEcCtD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	8.07e-05	0.000874	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CALM3—ulcerative colitis	7.93e-05	0.000858	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CALM3—ulcerative colitis	7.93e-05	0.000858	CbGpPWpGaD
Dapagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.83e-05	0.000847	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ADCY5—ulcerative colitis	7.59e-05	0.000821	CbGpPWpGaD
Dapagliflozin—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	7.45e-05	0.000806	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CHP1—ulcerative colitis	7.42e-05	0.000803	CbGpPWpGaD
Dapagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.41e-05	0.000802	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.97e-05	0.000754	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	6.91e-05	0.000748	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	6.89e-05	0.000745	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—ADCY5—ulcerative colitis	6.87e-05	0.000743	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—ADCY5—ulcerative colitis	6.87e-05	0.000743	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTGS1—ulcerative colitis	6.8e-05	0.000736	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	6.73e-05	0.000728	CbGpPWpGaD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	6.49e-05	0.000703	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—DLD—ulcerative colitis	6.41e-05	0.000693	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	6.36e-05	0.000688	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	6.31e-05	0.000682	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	6.28e-05	0.00068	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	6.28e-05	0.00068	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	6.19e-05	0.000669	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ABCB1—ulcerative colitis	6.17e-05	0.000667	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ABCB1—ulcerative colitis	6.17e-05	0.000667	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CALM3—ulcerative colitis	6.12e-05	0.000662	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	6.11e-05	0.000661	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CHP1—ulcerative colitis	6.03e-05	0.000653	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	5.93e-05	0.000642	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—PPARG—ulcerative colitis	5.89e-05	0.000637	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	5.76e-05	0.000624	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ADCY5—ulcerative colitis	5.75e-05	0.000622	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ADCY5—ulcerative colitis	5.75e-05	0.000622	CbGpPWpGaD
Dapagliflozin—UGT2B7—NRF2 pathway—TGFB1—ulcerative colitis	5.72e-05	0.000619	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PPARG—ulcerative colitis	5.66e-05	0.000613	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.65e-05	0.000611	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—JAK2—ulcerative colitis	5.65e-05	0.000611	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	5.55e-05	0.0006	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	5.52e-05	0.000597	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	5.5e-05	0.000595	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	5.39e-05	0.000583	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CD4—ulcerative colitis	5.36e-05	0.00058	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PTGS2—ulcerative colitis	5.32e-05	0.000575	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—DLD—ulcerative colitis	5.21e-05	0.000563	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	5.15e-05	0.000557	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ALB—ulcerative colitis	5.09e-05	0.000551	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	5.03e-05	0.000544	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.82e-05	0.000521	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.82e-05	0.000521	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ABCB1—ulcerative colitis	4.76e-05	0.000515	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	4.68e-05	0.000506	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CHP1—ulcerative colitis	4.65e-05	0.000503	CbGpPWpGaD
Dapagliflozin—UGT1A9—NRF2 pathway—TGFB1—ulcerative colitis	4.65e-05	0.000503	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	4.49e-05	0.000485	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL2—ulcerative colitis	4.47e-05	0.000483	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTGS2—ulcerative colitis	4.45e-05	0.000482	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ADCY5—ulcerative colitis	4.44e-05	0.000481	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PPARG—ulcerative colitis	4.29e-05	0.000464	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PPARG—ulcerative colitis	4.29e-05	0.000464	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	4.29e-05	0.000464	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—JAK2—ulcerative colitis	4.28e-05	0.000463	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—JAK2—ulcerative colitis	4.28e-05	0.000463	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	4.16e-05	0.00045	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—STAT3—ulcerative colitis	4.15e-05	0.000449	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CD4—ulcerative colitis	4.06e-05	0.000439	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CD4—ulcerative colitis	4.06e-05	0.000439	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PTGS2—ulcerative colitis	4.03e-05	0.000436	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PTGS2—ulcerative colitis	4.03e-05	0.000436	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—DLD—ulcerative colitis	4.01e-05	0.000434	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	4e-05	0.000433	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	4e-05	0.000433	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	3.97e-05	0.00043	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ALB—ulcerative colitis	3.86e-05	0.000417	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ALB—ulcerative colitis	3.86e-05	0.000417	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—TGFB1—ulcerative colitis	3.84e-05	0.000416	CbGpPWpGaD
Dapagliflozin—CYP2A6—NRF2 pathway—TGFB1—ulcerative colitis	3.58e-05	0.000388	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.49e-05	0.000377	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CHP1—ulcerative colitis	3.46e-05	0.000375	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTGS2—ulcerative colitis	3.38e-05	0.000365	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTGS2—ulcerative colitis	3.38e-05	0.000365	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PPARG—ulcerative colitis	3.31e-05	0.000358	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TNF—ulcerative colitis	3.25e-05	0.000352	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.25e-05	0.000351	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—STAT3—ulcerative colitis	3.14e-05	0.00034	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—STAT3—ulcerative colitis	3.14e-05	0.00034	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS1—ulcerative colitis	3.1e-05	0.000335	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3e-05	0.000325	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—DLD—ulcerative colitis	2.99e-05	0.000324	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ALB—ulcerative colitis	2.98e-05	0.000322	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—TGFB1—ulcerative colitis	2.91e-05	0.000315	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—TGFB1—ulcerative colitis	2.91e-05	0.000315	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—IL6—ulcerative colitis	2.9e-05	0.000313	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CALM3—ulcerative colitis	2.79e-05	0.000302	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CHP1—ulcerative colitis	2.77e-05	0.000299	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.75e-05	0.000298	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CHP1—ulcerative colitis	2.61e-05	0.000282	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTGS2—ulcerative colitis	2.61e-05	0.000282	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CHP1—ulcerative colitis	2.58e-05	0.00028	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS1—ulcerative colitis	2.52e-05	0.000272	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.48e-05	0.000268	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.42e-05	0.000262	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—DLD—ulcerative colitis	2.39e-05	0.000258	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.38e-05	0.000257	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CALM3—ulcerative colitis	2.27e-05	0.000245	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—DLD—ulcerative colitis	2.25e-05	0.000244	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—DLD—ulcerative colitis	2.23e-05	0.000241	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CHP1—ulcerative colitis	2.21e-05	0.000239	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—IL6—ulcerative colitis	2.2e-05	0.000238	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—IL6—ulcerative colitis	2.2e-05	0.000238	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ABCB1—ulcerative colitis	2.17e-05	0.000235	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.17e-05	0.000234	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.07e-05	0.000224	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.06e-05	0.000223	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ADCY5—ulcerative colitis	2.02e-05	0.000219	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS1—ulcerative colitis	1.94e-05	0.00021	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DLD—ulcerative colitis	1.91e-05	0.000206	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ABCB1—ulcerative colitis	1.76e-05	0.000191	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CALM3—ulcerative colitis	1.75e-05	0.000189	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.72e-05	0.000186	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.7e-05	0.000184	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ADCY5—ulcerative colitis	1.64e-05	0.000178	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.61e-05	0.000174	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.61e-05	0.000174	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.58e-05	0.000171	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PPARG—ulcerative colitis	1.51e-05	0.000163	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DLD—ulcerative colitis	1.47e-05	0.000159	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS1—ulcerative colitis	1.45e-05	0.000156	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.42e-05	0.000154	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.42e-05	0.000153	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ABCB1—ulcerative colitis	1.36e-05	0.000147	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ALB—ulcerative colitis	1.36e-05	0.000147	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CALM3—ulcerative colitis	1.3e-05	0.000141	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ADCY5—ulcerative colitis	1.27e-05	0.000137	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.24e-05	0.000135	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PPARG—ulcerative colitis	1.23e-05	0.000133	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—ulcerative colitis	1.19e-05	0.000128	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.18e-05	0.000128	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.15e-05	0.000125	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ALB—ulcerative colitis	1.1e-05	0.000119	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.09e-05	0.000118	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.08e-05	0.000117	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS1—ulcerative colitis	1.08e-05	0.000117	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.06e-05	0.000115	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CALM3—ulcerative colitis	1.04e-05	0.000112	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ABCB1—ulcerative colitis	1.01e-05	0.00011	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.01e-05	0.000109	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CALM3—ulcerative colitis	9.8e-06	0.000106	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CALM3—ulcerative colitis	9.71e-06	0.000105	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—ulcerative colitis	9.64e-06	0.000104	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PPARG—ulcerative colitis	9.45e-06	0.000102	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ADCY5—ulcerative colitis	9.44e-06	0.000102	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.28e-06	0.0001	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS1—ulcerative colitis	9.22e-06	9.97e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.07e-06	9.81e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ALB—ulcerative colitis	8.5e-06	9.2e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CALM3—ulcerative colitis	8.3e-06	8.98e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.93e-06	8.58e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ABCB1—ulcerative colitis	7.62e-06	8.24e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ABCB1—ulcerative colitis	7.55e-06	8.17e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ADCY5—ulcerative colitis	7.54e-06	8.16e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—ulcerative colitis	7.44e-06	8.04e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS1—ulcerative colitis	7.11e-06	7.7e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ADCY5—ulcerative colitis	7.11e-06	7.69e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ADCY5—ulcerative colitis	7.05e-06	7.62e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARG—ulcerative colitis	7.04e-06	7.62e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ABCB1—ulcerative colitis	6.45e-06	6.98e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.4e-06	6.93e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ALB—ulcerative colitis	6.33e-06	6.85e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ADCY5—ulcerative colitis	6.02e-06	6.51e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARG—ulcerative colitis	5.62e-06	6.09e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—ulcerative colitis	5.54e-06	5.99e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARG—ulcerative colitis	5.3e-06	5.73e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARG—ulcerative colitis	5.25e-06	5.69e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ALB—ulcerative colitis	5.06e-06	5.47e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.98e-06	5.39e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALB—ulcerative colitis	4.77e-06	5.16e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALB—ulcerative colitis	4.72e-06	5.11e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.65e-06	5.03e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARG—ulcerative colitis	4.49e-06	4.86e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—ulcerative colitis	4.42e-06	4.79e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—ulcerative colitis	4.17e-06	4.51e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—ulcerative colitis	4.13e-06	4.47e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALB—ulcerative colitis	4.04e-06	4.37e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—ulcerative colitis	3.53e-06	3.82e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.47e-06	3.75e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALB—ulcerative colitis	3.12e-06	3.37e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.73e-06	2.95e-05	CbGpPWpGaD
